We are live on ! Find out more
VIA

Virtus Investment Advisers Portfolio holdings

AUM $363M
1-Year Est. Return 34.89%
This Fund
S&P 500
This Quarter Est. Return
+5.04%
1 Year Est. Return
+34.89%
3 Year Est. Return
+131.43%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$363M
AUM Growth
-$5.41M
Cap. Flow
+$2.38M
Cap. Flow %
0.66%
Top 10 Hldgs %
7.17%
Holding
495
New
34
Increased
285
Reduced
131
Closed
45

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$2.11M
2
HSY icon
Hershey
HSY
+$2.09M
3
GILD icon
Gilead Sciences
GILD
+$2.07M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$2.05M
5
EIX icon
Edison International
EIX
+$2.04M

Top Sells

Rank Stock Value
1
HBAN icon
Huntington Bancshares
HBAN
+$2.13M
2
TKO icon
TKO Group
TKO
+$2.13M
3
WAT icon
Waters Corp
WAT
+$2.09M
4
STT icon
State Street
STT
+$2.07M
5
AON icon
Aon
AON
+$2.04M

Sector Composition

Rank Sector Weight
1 Healthcare 31.87%
2 Financials 20.97%
3 Technology 10.66%
4 Industrials 10.62%
5 Consumer Discretionary 7.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRSP icon
176
CRISPR Therapeutics
CRSP
$4.68B
$709K 0.2%
14,894
+2,838
+24% +$150K
INSM icon
177
Insmed
INSM
$23.3B
$700K 0.19%
4,283
+815
+24% +$125K
NMFC icon
178
New Mountain Finance
NMFC
$644M
$694K 0.19%
89,471
+3,609
+4% +$30.1K
ACAD icon
179
Acadia Pharmaceuticals
ACAD
$4.25B
$692K 0.19%
31,095
+5,925
+24% +$142K
IMCR icon
180
Immunocore
IMCR
$1.81B
$692K 0.19%
22,940
+4,371
+24% +$141K
ARQT icon
181
Arcutis Biotherapeutics
ARQT
$3.42B
$685K 0.19%
29,092
+5,543
+24% +$141K
LEGN icon
182
Legend Biotech
LEGN
$4.55B
$684K 0.19%
37,824
+7,207
+24% +$137K
KURA icon
183
Kura Oncology
KURA
$928M
$672K 0.19%
82,610
+15,740
+24% +$135K
RWAY icon
184
Runway Growth Finance
RWAY
$232M
$665K 0.18%
96,849
-1,130
-1% -$9.39K
VVR icon
185
Invesco Senior Income Trust
VVR
$457M
$654K 0.18%
203,173
-49,411
-20% -$159K
RYTM icon
186
Rhythm Pharmaceuticals
RYTM
$7.04B
$647K 0.18%
7,434
+1,417
+24% +$138K
PHAT icon
187
Phathom Pharmaceuticals
PHAT
$925M
$644K 0.18%
57,986
+11,049
+24% +$140K
ELVN icon
188
Enliven Therapeutics
ELVN
$3.77B
$634K 0.17%
16,173
+395
+3% +$10.9K
MFIC icon
189
MidCap Financial Investment
MFIC
$779M
$621K 0.17%
55,212
-5,024
-8% -$55.4K
GBDC icon
190
Golub Capital BDC
GBDC
$3.33B
$612K 0.17%
48,365
+2,450
+5% +$31.4K
CION icon
191
CION Investment
CION
$296M
$612K 0.17%
89,408
+14,979
+20% +$126K
TNGX icon
192
Tango Therapeutics
TNGX
$4.47B
$610K 0.17%
29,163
+711
+2% +$9.9K
CGBD icon
193
Carlyle Secured Lending
CGBD
$696M
$610K 0.17%
55,723
-7,963
-13% -$94K
CRNX icon
194
Crinetics Pharmaceuticals
CRNX
$8.85B
$607K 0.17%
16,721
+3,186
+24% +$142K
HRZN icon
195
Horizon Technology Finance
HRZN
$301M
$606K 0.17%
143,968
-23,556
-14% -$136K
PFLT icon
196
PennantPark Floating Rate Capital
PFLT
$683M
$603K 0.17%
75,014
-4,687
-6% -$41.2K
SPMC
197
Sound Point Meridian Capital
SPMC
$209M
$601K 0.17%
67,142
+37,522
+127% +$437K
ESPR
198
DELISTED
Esperion Therapeutics
ESPR
$601K 0.17%
219,293
+41,785
+24% +$132K
HRMY icon
199
Harmony Biosciences
HRMY
$2.07B
$584K 0.16%
20,840
+3,971
+24% +$130K
GAIN icon
200
Gladstone Investment Corp
GAIN
$638M
$583K 0.16%
41,033
-8,462
-17% -$118K
6 7
8
9 10

Similar funds

RC
Reik & Co New York $363M AUM 3.03% 1-Year Est. Return
MS
Millington Securities Red Bank, New Jersey $362M AUM
WI
WBI Investments Red Bank, New Jersey $362M AUM 23.75% 1-Year Est. Return
HS
HighVista Strategies Boston, Massachusetts $362M AUM 230.96% 1-Year Est. Return
SIAG
Safeguard Investment Advisory Group Corona, California $362M AUM 20.96% 1-Year Est. Return
BHBT
Burke & Herbert Bank & Trust Alexandria, Virginia $362M AUM 20.5% 1-Year Est. Return
WTFG
Wood Tarver Financial Group Boise, Idaho $362M AUM 14.75% 1-Year Est. Return
MA
Modus Advisors Excelsior, Minnesota $363M AUM 22.99% 1-Year Est. Return

Virtus Investment Advisers's Q1 2026 Portfolio in Review

As of Q1 2026, Virtus Investment Advisers held 495 positions worth $363M, down 1.5% from $368M the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.

Virtus Investment Advisers's Q1 2026 filing shows 34 new, 285 increased, 131 reduced and 45 closed positions. Its largest new stake was Hershey: 9,903 shares worth $2.06M. The largest sale was Huntington Bancshares, an estimated $2.13M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 27% a quarter earlier, followed by Financials and Technology.

  • Virtus Investment Advisers's largest Q1 2026 buy was Hershey: 9,903 shares worth $2.06M.
  • Virtus Investment Advisers added most to Amgen in Q1 2026, an estimated $2.11M increase.
  • Virtus Investment Advisers's biggest Q1 2026 reduction was Micron Technology, cutting an estimated $1.56M.
  • Virtus Investment Advisers fully exited Huntington Bancshares in Q1 2026, selling an estimated $2.13M.
  • Virtus Investment Advisers's ten largest holdings make up 7.2% of its $363M portfolio in Q1 2026.
  • Virtus Investment Advisers opened 34 new positions and closed 45 in Q1 2026.
  • Virtus Investment Advisers's portfolio value fell 1.5% quarter-over-quarter to $363M.

Based on Virtus Investment Advisers's 13F filing for Q1 2026, filed 14 May 2026.